Literature DB >> 32543971

Increased CD4/CD8 ratio as a risk factor for critical illness in coronavirus disease 2019 (COVID-19): a retrospective multicentre study.

Carlo Pallotto1,2, Lorenzo Roberto Suardi1, Sara Esperti1, Roberto Tarquini3, Elisa Grifoni4, Simone Meini5, Alice Valoriani3, Stefania Di Martino4, Francesco Cei3, Eleonora Sisti4, Fiorella Piani5, Annarita Botta1,6, Elena Salomoni1, Filippo Baragli1, Pierluigi Blanc1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32543971     DOI: 10.1080/23744235.2020.1778178

Source DB:  PubMed          Journal:  Infect Dis (Lond)        ISSN: 2374-4243


× No keyword cloud information.
  13 in total

1.  Supervised Machine Learning Approach to Identify Early Predictors of Poor Outcome in Patients with COVID-19 Presenting to a Large Quaternary Care Hospital in New York City.

Authors:  Jason Zucker; Angela Gomez-Simmonds; Lawrence J Purpura; Sherif Shoucri; Elijah LaSota; Nicholas E Morley; Brit W Sovic; Marvin A Castellon; Deborah A Theodore; Logan L Bartram; Benjamin A Miko; Matthew L Scherer; Kathrine A Meyers; William C Turner; Maureen Kelly; Martina Pavlicova; Cale N Basaraba; Matthew R Baldwin; Daniel Brodie; Kristin M Burkart; Joan Bathon; Anne-Catrin Uhlemann; Michael T Yin; Delivette Castor; Magdalena E Sobieszczyk
Journal:  J Clin Med       Date:  2021-08-11       Impact factor: 4.964

2.  Individuals With Higher CD4/CD8 Ratio Exhibit Increased Risk of Acute Respiratory Distress Syndrome and In-Hospital Mortality During Acute SARS-CoV-2 Infection.

Authors:  Ana Pascual-Dapena; Juan José Chillaron; Gemma Llauradó; Isabel Arnau-Barres; Juana Flores; Inmaculada Lopez-Montesinos; Luisa Sorlí; Juan Luis Martínez-Pérez; Silvia Gómez-Zorrilla; Juan Du; Natalia García-Giralt; Robert Güerri-Fernández
Journal:  Front Med (Lausanne)       Date:  2022-06-23

3.  The selection of indicators from initial blood routine test results to improve the accuracy of early prediction of COVID-19 severity.

Authors:  Jiaqing Luo; Lingyun Zhou; Yunyu Feng; Bo Li; Shujin Guo
Journal:  PLoS One       Date:  2021-06-15       Impact factor: 3.240

4.  Role of the Immune Microenvironment in SARS-CoV-2 Infection.

Authors:  Chih-Hung Ye; Wen-Lin Hsu; Guan-Ru Peng; Wei-Chieh Yu; Wei-Chen Lin; SuiYun Hu; Shu-Han Yu
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

5.  Combination of the CD8+:B-cell and Neutrophil-to-Lymphocyte Ratio as a Novel Prediction Model for Intubation Need and Disease Severity in COVID-19 Patients.

Authors:  Maria G Detsika; Eirini Grigoriou; Katherina Psarra; Edison Jahaj; Stamatios Tsipilis; Nikolaos Athanassiou; Alexandros Zacharis; Ioanna Dimopoulou; Stylianos E Orfanos; Alexandra Tsirogianni; Anastasia Kotanidou
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

6.  High CD4-to-CD8 ratio identifies an at-risk population susceptible to lethal COVID-19.

Authors:  Marco De Zuani; Petra Lazničková; Veronika Tomašková; Martina Dvončová; Giancarlo Forte; Gorazd Bernard Stokin; Vladimir Šrámek; Martin Helán; Jan Frič
Journal:  Scand J Immunol       Date:  2021-12-13       Impact factor: 3.889

7.  Associations of immunological features with COVID-19 severity: a systematic review and meta-analysis.

Authors:  Zhicheng Zhang; Guo Ai; Liping Chen; Shunfang Liu; Chen Gong; Xiaodong Zhu; Chunli Zhang; Hua Qin; Junhui Hu; Jinjin Huang
Journal:  BMC Infect Dis       Date:  2021-08-03       Impact factor: 3.090

Review 8.  Oxidative Stress-Related Mechanisms in SARS-CoV-2 Infections.

Authors:  Joanna Wieczfinska; Paulina Kleniewska; Rafal Pawliczak
Journal:  Oxid Med Cell Longev       Date:  2022-03-08       Impact factor: 6.543

9.  Potential remdesivir-related transient bradycardia in patients with coronavirus disease 2019 (COVID-19).

Authors:  Carlo Pallotto; Lorenzo R Suardi; Andrea Gabbuti; Sara Esperti; Lorenzo Mecocci; Pierluigi Blanc
Journal:  J Med Virol       Date:  2021-03-03       Impact factor: 2.327

10.  Peripheral biomarkers' panel for severe COVID-19 patients.

Authors:  Miriana d'Alessandro; Laura Bergantini; Paolo Cameli; Giuseppe Curatola; Lorenzo Remediani; Piersante Sestini; Elena Bargagli
Journal:  J Med Virol       Date:  2020-10-10       Impact factor: 20.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.